Plasmodium vivax trophozoite-stage proteomes

Journal of Proteomics

Volumn 115, Issue , 2015, Pages 157-176

  Anderson, D C ^a   Lapp, Stacey A ^b   Akinyi, Sheila ^b   Meyer, Esmeralda V S ^b   Barnwell, John W ^c   Korir Morrison, Cindy ^b   Galinski, Mary R ^b,d  

^a SRI INTERNATIONAL   (United States)

^b EMORY UNIVERSITY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Infected red blood cell; Malaria; Plasmodium vivax; Protein oxidation nitration; Proteomics; Trophozoite stage

Indexed keywords

2,4 DINITROPHENYLHYDRAZINE; HEMOGLOBIN; PROTEOME; PROTOZOAL PROTEIN;

ANIMAL CELL; ARTICLE; ERYTHROCYTE; HOST CELL; HOST PARASITE INTERACTION; HOST RANGE; MOLECULAR PATHOLOGY; NITRATION; NONHUMAN; OXIDATION; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEOMICS; RETICULOCYTE; SAIMIRI BOLIVIENSIS; TANDEM MASS SPECTROMETRY; TROPHOZOITE; WESTERN BLOTTING; ANIMAL; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; PHYSIOLOGY; SQUIRREL MONKEY;

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIMATES; SAIMIRI BOLIVIENSIS;

ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; PLASMODIUM VIVAX; PROTEOME; PROTOZOAN PROTEINS; SAIMIRI; TROPHOZOITES;

EID: 84927135920     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.12.010     Document Type: Article

References (106)

1. Gething P., Elyazar I., Moyes C., Smith D., Battle K., Guerra C. A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis 2012, 10.1371/journal.pntd. 0001814.
2. Mendis K., Sina B., Marchesini P., Carter R. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 2001, 64S:97-106.
3. Mueller I., Galinski M.R., Baird J.K., Carlton J.M., Kochar D.K., Alonso P.L., et al. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis 2009, 9:555-566.
4. McGready R., Wongsaen K., Chu C., Tun N., Chotivanich K., White N., et al. Uncomplicated Plasmodium vivax malaria in pregnancy associated with mortality from acute respiratory distress syndrome. Malar J 2014, 13:191.
5. Galinski M.R., Barnwell J.W. Plasmodium vivax: who cares?. Malar J 2008, 7:S9-S27.
6. Galinski M., Meyer E., Barnwell J. Plasmodium vivax: modern strategies to study a persistent parasite's life cycle. Adv Parasitol 2013, 81:1-26.
7. Waters A.P., Higgins D.G., McCutchan T.F. Evolutionary relatedness of some primate models of Plasmodium. Mol Biol Evol 1993, 10:914-923.
8. Alonso P., Brown G., Arevalo-Herrera M., Binka F., Chitnis C., Collins F. A research agenda to underpin malaria eradication. PLoS Med 2011, 8:e1000406.
9. Coronado L., Nadovich C., Spadafora C. Malarial hemozoin: from target to tool. Biochim Biophys Acta 2014, 1840:2032-2041.
10. Kitchen S.K. The infection of reticulocytes by Plasmodium vivax. Am J Trop Med Hyg 1938, 18:347-353.
11. Prajapati S.K., Singh O.P. Insights into the invasion biology of Plasmodium vivax. Front Cell Infect Microbiol 2013, 3:8.
12. Matsumoto Y., Matsuda S., Yoshida Y. Ultrastructure of human erythrocytes infected with Plasmodium ovale. Am J Trop Med Hyg 1986, 35:697-703.
13. Aikawa M., Miller L.H., Rabbege J. Caveola-vesicle complexes in the plasma lemma of erythrocytes infected by Plasmodium vivax and P. cynomolgi. Unique structures related to Schffner's dots. Am J Pathol 1975, 79:285-300.
14. Akinyi S., Hanssen E., Meyer E.V., Jiang J., Korir C.C., Singh B., et al. A 95kDa protein of Plasmodium vivax and P. cynomolgi visualized by three-dimensional tomography in the caveola-vesicle complexes (Schffner's dots) of infected erythrocytes is a member of the PHIST family. Mol Microbiol 2012, 84:816-831.
15. Barnwell J.W., Ingravallo P., Galinski M.R., Matsumoto Y., Aikawa M. Plasmodium vivax: malarial proteins associated with the membrane-bound caveola-vesicle complexes and cytoplasmic cleft structures of infected erythrocytes. Exp Parasitol 1990, 70:85-99.
16. Tachibana S., Sullivan S.A., Kawai S., Nakamura S., Kim H.R., Goto N., et al. Plasmodium cynomolgi genome sequences provide insight into Plasmodium vivax and the monkey malaria clade. Nat Genet 2012, 44:1051-1055.
17. Lopez F.J., Bernabeu M., Fernandez-Becerra C., del Portillo H.A. A new computational approach redefines the subtelomeric vir superfamily of Plasmodium vivax. BMC Genomics 2013, 14:8.
18. del Portillo H., Fernandez-Becerra C., Bowman S., Oliver K., Preuss M., Sanchez C.P., et al. A superfamily of variant genes encoded in the subtelomeric region of Plasmodium vivax 2001, 410:839-842.
19. Bernabeu M., Lopez F.J., Ferrer M., Martin-Jaular L., Razaname A., Corradin G., et al. Functional analysis of Plasmodium vivax VIR proteins reveals different subcellular localizations and cytoadherence to the ICAM-1 endothelial receptor. Cell Microbiol 2012, 14:386-400.
20. Arnot D.E., Jensen A.T. Antigenic variation and the genetics and epigenetics of the PfEMP1 erythrocyte surface antigens in Plasmodium falciparum malaria. Adv Appl Microbiol 2011, 74:77-96.
21. Lapp S.A., Korir-Morrison C., Jiang J., Bai Y., Corredor V., Galinski M.R. Spleen-dependent regulation of antigenic variation in malaria parasites: Plasmodium knowlesi SICAvar expression profiles in splenic and asplenic hosts. PLoS One 2013, 8:e78014.
22. Galinski M.R., Barnwell J.W. Non-human primate model for human malaria research. Nonhuman Primates in Biomedical Research: Diseases 2012, 2e:299-323. Elsevier Inc.: Academic Press. C.R. Abee, K. Mansfield, S.D. Tardif, T. Morris (Eds.).
23. Carlton J., Adams J., Silva J., Bidwell S., Lorenzi H., Caler E. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 2008, 455:757-763.
24. Acharya P., Pallavi R., Chandran S., Chakravarti H., Middha S., Acharya J., et al. A glimpse into the clinical proteome of human malaria parasites Plasmodium falciparum and Plasmodium vivax. Proteomics Clin Appl 2009, 3:1314-1325.
25. Acharya P., Pallavi R., Chandran S., Dandavate V., Sayeed S., Rochani A., et al. Clinical proteomics of the neglected human malarial parasite Plasmodium vivax. PLoS One 2011, 6:e26623.
26. Roobsoong W., Roytrakul S., Sattabongkot J., Li J., Udomsangpetch R., Cui L. Determination of the Plasmodium vivax schizont stage proteome. J Proteomics 2011, 74:1701-1710.
27. Moreno-Perez D., Degano R., Ibarrola N., Muro A., Patarroyo M. Determining the Plasmodium vivax VCG-1 strain blood stage proteome. J Proteomics 2015, 113:268-280.
28. Ray S., Kamath K., Srivastava R., Raghu D., Gollapalli K., Jain R., et al. Serum proteome analysis of vivax malaria: an insight into the disease pathogenesis and host immune response. J Proteomics 2012, 75:3063-3080.
29. Ray S., Renu D., Srivastava R., Gollapalli K., Taur S., Jhaveri T., et al. Proteomic investigation of falciparum and vivax malaria for identification of surrogate protein markers. PLoS One 2012, 7:e41751.
30. Gruys E., Toussaint M., Niewold T., Koopmans S. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B 2005, 6:1045-1056.
31. Lu F., Li J., Wang B., Cheng Y., Kong D., Cui L., et al. Profiling the humoral immune responses to Plasmodium vivax infection and identification of candidate immunogenic rhoptry-associated membrane antigen (RAMA). J Proteomics 2014, 102:66-82.
32. Collins W.E., Sullivan J.S., Galland G.G., Williams A., Nace D., Williams T., et al. Plasmodium simium and Saimiri boliviensis as a model system for testing candidate vaccines against Plasmodium vivax. Am J Trop Med Hyg 2005, 73:644-648.
33. Langhorne J., Buffet P., Galinski M., Good M., Harty J., Leroy D., et al. Malar J 2011, 10:23-26.
34. Galinski M.R., Barnwell J.W. Non-human primate model for human malaria research. Nonhuman Primates in Biomedical Research: Diseases 2012, 2e:299-323. Elsevier Inc. C.R. Abee, K. Mansfield, S.D. Tardif, T. Morris (Eds.).
35. Radfar A., Diez A., Bautista J. Chloroquine mediates specific proteome oxidative damage across the erythrocytic cycle of resistant Plasmodium falciparum. Free Radic Biol Med 2008, 44:2034-2042.
36. Wang R., Marcotte E. The proteomic response of Mycobacterium smegmatis to anti-tuberculosis drugs suggests targeted pathways. J Proteome Res 2008, 7:855-865.
37. Wisniewski J., Zougman A., Nararaj N., Mann M. Universal sample preparation method for proteome analysis. Nat Methods 2009, 6:359-362.
38. Chopra S., Ramkissoon K., Anderson D.C. A systematic quantitative proteomic examination of multidrug resistance in Acinetobacter baumannii. J Proteomics 2013, 84:17-39.
39. Olsen J., de Godoy L., Li G., Macek B., Mortensen P., Pesch R., et al. Parts per million mass accuracy on an orbitrap mass spectrometer via lock mass injection into a C-trap. Mol Cell Proteomics 2005, 4:2010-2025.
40. Cox J., Neuhauser N., Michalski A., Scheltema R.A., Olsen J.V., Mann M. Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res 2011, 10:1794-1805.
41. Xu H., Freitas M. A mass accuracy sensitive probability based scoring algorithm for database searching of tandem mass spectrometry data. BMC Bioinformatics 2007, 20:133-143.
42. Bjornson R.D., Carriero N.J., Colangelo C., Shifman M., Cheung K.H., Miller P.L., et al. X!!Tandem, an improved method for running X!Tandem in parallel on collections of commodity computers. J Proteome Res 2008, 7:293-299.
43. Perkins D., Pappin D., Creasy D., Cottrell J. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20:3551-3567.
44. Kall L., Canterbury J.D., Weston J., Noble W.S., MacCoss M. A semi-supervised machine learning technique for peptide identification from shotgun proteomics datasets. Nat Methods 2007, 4:923-925.
45. Eng J., McCormack A., Yates J. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom 1994, 5:976-989.
46. Nesvizhskii A.I., Keller A., Kolker E., Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003, 75:4646-4658.
47. Yu W., Taylor J.A., Davis M.T., Bonilla L.E., Lee K.A., Auger P.L., et al. Maximizing the sensitivity and reliability of peptide identification in large-scale proteomic experiments by harnessing multiple search engines. Proteomics 2010, 10:1172-1189.
48. Zhang X., Monroe M.E., Chen B., Chin M.H., Heibeck T.H., Schepmoes A.A., et al. Endogenous 3,4-dihydroxyphenylalanine and dopaquinone modifications on protein tyrosine: links to mitochondrially derived oxidative stress via hydroxyl radical. Mol Cell Proteomics 2010, 9:1199-1208.
49. Korir C.C., Galinski M.R. Proteomic studies of Plasmodium knowlesi SICA variant antigens demonstrate their relationship with P. falciparum EMP1. Infect Genet Evol 2006, 6:75-79.
50. Prieto J., Koncarevic S., Park S., Yates J., Becker K. Large scale differential proteome analysis in Plasmodium falciparum under drug treatment. PLoS One 2008, 3:e4098.
51. Ostell J. The Entrez search and retrieval system. The NCBI Handbook [Internet] 2002, National Center for Biotechnology Information (US), Bethesda (MD), [Chapter 15]. J. McEntyre, J. Ostell (Eds.).
52. Finn R., Clements J., Eddy S. HMMER web server: interactive sequence similarity searching. Nucleic Acids Res 2011, 39:W29-W37.
53. Altschul S., Gish W., Miller W., Myers E., Lipman D. Basic local alignment search tool. J Mol Biol 1990, 215:403-410.
54. Hunter S., Jones P., Mitchell A., Apweiler R., Attwood T., Bateman A., et al. InterPro in 2011: new developments in the family and domain prediction database. Nucleic Acids Res 2012, 40:D306-D312.
55. Ishihama Y., Oda Y., Tabata T., Sato T., Nagasu T., Rappsilber J., et al. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 2005, 4:1265-1272.
56. Spielmann T., Montagna G.N., Hecht L., Matuschewski K. Molecular make-up of the Plasmodium parasitophorous vacuolar membrane. Int J Med Microbiol 2012, 302:179-186.
57. Rebrin I., Bregere C., Gallaher T.K., Sohal R. Detection and characterization of peroxynitrite-induced modifications of tyrosine, sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1. J Biol Chem 2008, 284:6476-6485.
58. Aslan M., Ryan T., Towness T., Coward L., Kirk M., Barnes S., et al. Nitric oxide-dependent generation of reactive species in sickle cell disease. J Biol Chem 2003, 278:4194-4204.
59. Marchler-Bauer A., Lu S., Anderson J.B., Chitsaz F., Derbyshire M.K., DeWeese-Scott C. CDD: a conserved domain database for the functional annotation of proteins. Nucleic Acids Res 2011, 39:D225-D229.
60. Bautista J., Marin-Garcia P., Diez A., Azcarate I., Puyet A. Malaria proteomics: insights into the parasite-host interactions in the pathogenic space. J Proteomics 2014, 97:107-125.
61. http://systemsbiology.emory.edu.
62. Langhorne J., Buffet P., Galinski M., Good M., Harty J., Leroy D., et al. The relevance of non-human primate and rodent malaria models for humans. Malar J 2011, 10:23-26.
63. Griffin T.J., Gygi S.P., Ideker T., Rist B., Eng J., Hood L., et al. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteomics 2002, 1:323-333.
64. Maier T., Güell M., Serrano L. Correlation of mRNA and protein in complex biological samples. FEBS Lett 2009, 583:3966-3973.
65. Stevens S.G., Brown C.M. In silico estimation of translation efficiency in human cell lines: potential evidence for widespread translational control. PLoS One 2013, 8:e57625.
66. Foth B.J., Zhang N., Mok S., Preiser P.R., Bozdech Z. Quantitative protein expression profiling reveals extensive post-transcriptional regulation and post-translational modifications in schizont-stage malaria parasites. Genome Biol 2008, 9:R177.
67. Foth B.J., Zhang N., Chaal B.K., Sze S.K., Preiser P.R., Bozdech Z. Quantitative time-course profiling of parasite and host cell proteins in the human malaria parasite Plasmodium falciparum. Mol Cell Proteomics 2011, 10. [M110.006411].
68. Bozdech Z., Mok S., Hu G., Imwong M., Jaidee A., Russell B., et al. The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites. Proc Natl Acad Sci U S A 2008, 105:16290-16295.
69. Ho M., Bannister L., Looareesuwan S., Suntharasamai P. Cytoadherence and ultrastructure of Plasmodium falciparum-infected erythrocytes from a splenectomized patient. Infect Immun 1992, 60:2225-2228.
70. Anderson D.C., Li W., Payan D.G., Noble W.S. A new algorithm for the evaluation of shotgun peptide sequencing in proteomics: support vector machine classification of peptide MS/MS spectra and SEQUEST scores. J Proteome Res 2003, 2:137-146.
71. Florens L., Washburn M.P., Raine J.D., Anthony R.M., Grainger M., Haynes J. A proteomic view of the Plasmodium falciparum life cycle. Nature 2002, 419:520-526.
72. Westenberger S.J., McClean C.M., Chattopadhyay R., Dharia N.V., Carlton J.M., Barnwell J.W., et al. A systems-based analysis of Plasmodium vivax lifecycle transcription from human to mosquito. PLoS Negl Trop Dis 2010, 4:e653.
73. Bozdech Z., Llinas M., Pulliam B., Wong E., Zhu J., DeRisi J. The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol 2003, 1:85-100.
74. Pesciotta E.N., Sriswasdi S., Tang H.Y., Mason P.J., Bessler M., Speicher D.W. A label-free proteome analysis strategy for identifying quantitative changes in erythrocyte membranes induced by red cell disorders. J Proteomics 2012, 76:194-202. [Spec No.].
75. Goodman S.R., Daescu O., Kakhniashvili D.G., Zivanic M. The proteomics and interactomics of human erythrocytes. Exp Biol Med (Maywood) 2013, 238:509-518.
76. Pasini E., Kirkegaard M., Mortensen P., Mann M., Thomas A. Deep-coverage rhesus red blood cell proteome: a first comparison with the human and mouse red blood cell. Blood Transfus 2010, 8(Suppl. 3):s126-s139.
77. von Lohneysen K., Scott T., Soldau K., Xu X., Friedman J. Assessment of the red cell proteome of young patients with unexplained hemolytic anemia by two-dimensional differential in-gel electrophoresis (DIGE). PLoS One 2012, 7:e34237.
78. Seppi C., Castellana M., Minetti G., Piccinini G., Balduini C., Brovelli A. Evidence for membrane protein oxidation during in vivo aging of human erythrocytes. Mech Ageing Dev 1991, 57:247-258.
79. Smith J., Jiang X., Abraham E. Identification of hydrogen peroxide oxidation sites of alpha A- and alpha B-crystallins. Free Radic Res 1997, 26:103-111.
80. Davies M.J. The oxidative environment and protein damage. Biochim Biophys Acta 2005, 1703:93-109.
81. Beck-Speier I., Leuschel L., Luippold G., Maier K. Proteins released from stimulated neutrophils contain very high levels of oxidised methionine. FEBS Lett 1988, 227:1-4.
82. Hoshi T., Heinemann S. Regulation of cell function by methionine oxidation and reduction. J Physiol 2001, 531:1-11.
83. Froelich J.M., Reid G.E. The origin and control of ex vivo oxidative peptide modifications prior to mass spectrometry analysis. Proteomics 2008, 8:1334-1345.
84. Stadtman E.R., Berlett B.S. Reactive oxygen-mediated protein oxidation in aging and disease. Chem Res Toxicol 1997, 10:485-494.
85. Boys B., Kuprowski M., Noe J., Konermann L. Protein oxidative modifications during electrospray ionization: solution phase electrochemistry or corona discharge-induced radical attack?. Anal Chem 2009, 81:4027-4034.
86. Choi J., Sullards M.C., Olzmann J.A., Rees H.D., Weintraub S.T., Bostwick D.E., et al. Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J Biol Chem 2006, 281:10816-10824.
87. Spickett C.M., Pitt A.R. Protein oxidation: role in signalling and detection by mass spectrometry. Amino Acids 2012, 42:5-21.
88. Van der Vliet A., O'Neill C.A., Halliwell B., Cross C.E., Kaur H. Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite. FEBS Lett 1994, 339:89-92.
89. Cudic M., Dendane M., HouÇ-Levin C., Ducrocq C. Nitration of angiotensin II by.NO2 radicals and peroxynitrite.NO protects against.NO2 radical reaction. Eur J Biochem 1999, 265:967-971.
90. Thorup C., Kornfeld M., Winaver J.M., Goligorsky M.S., Moore L.C. Angiotensin II stimulates nitric oxide release in isolated perfused renal resistance arteries. Pflugers Arch Eur J Physiol 1998, 435:432-434.
91. Lee S., Chen Y., Luo H., Wu A.A., Wilde M., Schumacker P.T., et al. The first global screening of protein substrates bearing protein-bound 3,4-dihydroxyphenylalanine in Escherichia coli and human mitochondria. J Proteome Res 2010, 9:5705-5714.
92. Moller M., Hatch D., Kim H., Porter N. Superoxide reaction with tyrosyl radicals generates para-hydroperoxy and para-hydroxy derivatives of tyrosine. J Am Chem Soc 2012, 34:16773-16780.
93. Wilkinson F., Helman W., Ross A. Rate constants for the decay and reactions of the lowest electronically excited state of molecular oxygen in solution. An expanded and revised compilation. J Phys Chem Ref Data 1995, 24:663-1021.
94. Uzasci L., Bianchet M., Cotter R., Nath A. Identification of nitrated immunoglobulin variable regions in the HIV-infected human brain: implications in HIV infection and immune response. J Proteome Res 2014, 13:1614-1623.
95. Becker K., Tilley L., Vennerstrom J.L., Roberts D., Rogerson S., Ginsburg H. Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Int J Parasitol 2004, 34:163-189.
96. Leoratti F.M., Trevelin S.C., Cunha F.Q., Rocha B.C., Costa P.A., Gravina H.D., et al. Neutrophil paralysis in Plasmodium vivax malaria. PLoS Negl Trop Dis 2012, 6:e1710.
97. Francis S.E., Sullivan D.J., Goldberg D.E. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu Rev Microbiol 1997, 51:97-123.
98. Muller S. Redox and antioxidant systems of the malaria parasite Plasmodium falciparum. Mol Microbiol 2004, 53:1291-1305.
99. Ferreira A., Balla J., Jeney V., Balla G., Soares M. A central role for free heme in the pathogenesis of severe malaria: the missing link?. J Mol Med 2008, 86:1097-1111.
100. Cappadoro M., Giribaldi G., O'Brien E., Turrini F., Mannu F., Ulliers D., et al. Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood 1998, 92:2527-2534.
101. Mendez D., Linares M., Diez A., Puyet A., Bautista J. Stress response and cytoskeletal proteins involved in erythrocyte membrane remodeling upon Plasmodium falciparum invasion are differentially carbonylated in G6PD A-deficiency. Free Radic Biol Med 2011, 50:1305-1313.
102. Mendez D., Hernaez M., Kamali A., Diez A., Puyet A. Differential carbonylation of cytoskeletal proteins in blood group O erythrocytes: potential role in protection against severe malaria. Infect Genet Evol 2012, 12:1780-1787.
103. Levine R., Mosoni L., Berlett B., Stadtman E. Methionine residues as endogenous antioxidants in proteins. Proc Natl Acad Sci U S A 1996, 93:15036-15040.
104. Cyrklaff M., Sanchez C., Frischknecht F., Lanzer M. Host actin remodeling and protection from malaria by hemoglobinopathies. Trends Parasitol 2012, 28:479-485.
105. Cyrklaff M., Sanchez C., Kilian N., Bisseye C., Simpore J., Frischknecht F., et al. Hemoglobins S and C interfere with actin remodeling in Plasmodium falciparum-infected erythrocytes. Science 2011, 334:1283-1286.
106. Federova M., Kuleva N., Hoffmann R. Identification of cysteine, methionine and tryptophan residues of actin oxidized in vivo during oxidative stress. J Proteome Res 2010, 9:1598-1609.